EXAMINE THIS REPORT ON HEMGENIX

Amount of suitable clients: CDEC talked over the uncertainty in the volume of people with moderately intense to extreme hemophilia B in Canada suitable for etranacogene dezaparvovec. Medical specialists consulted by CADTH indicated that some individuals who're categorized as getting mild or average sickness can have a critical bleeding phenotype, w